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Historical perspective. The Cedars-Sinai group has made 
major contributions to furthering the understanding of the 
diagnostic and prognostic applications of exercise or phar- 
macologic stress myocardial perfusion in patients with 
suspected or known coronary artery disease (CAD). In two 
studies published in 1986 and 1987, Dr. Berman et al. (1) 
showed the extent and severity of exercise-induced 2°1T1 
defects on planar images were independent predictors of 
future cardiac events (2,3). These reports comprised the 
largest number of patients ever studied up to that time 
regarding the assessment of the prognostic value of a 
noninvasive imaging technique, and the study by Laden- 
helm et al. (3) was the first to demonstrate he incremental 
prognostic power of clinical variables, exercise electrocar- 
diographic (ECG) stress test variables and myocardial 
perfusion imaging data. They extended the important initial 
observations of Brown et al. (4), who showed that the 
number of reversible 2°1T1 defects on stress cintigrams was 
the best predictor of death and nonfatal infarction in 100 
patients without prior infarction who underwent exercise 
planar 2°XT1 scintigraphy. Using stepwise logistic regression 
analysis, Ladenheim et al. (3) identified the number of 
myocardial scan segments with reversible 2°1T1 defects and 
the exercise heart rate as the only independent predictors of 
subsequent events in 1,689 CAD patients without prior 
infarction. Other investigators confirmed or extended these 
findings (5-7), and collectively, these studies published in 
the 1980s showed that patients with normal perfusion scans 
had a <1% per year cardiac death or nonfatal infarction rate, 
whereas those with abnormal scans, particularly those show- 
ing a multivessel disease pattern, increased lung 2°aT1 
uptake or transient ischemic left ventricular cavity dilation 
had a significantly higher event rate. 
Prognostic value of 99mTc-sestamibi SPECT. For many 
years, planar and single-photon emission computed tomog- 
raphy (SPECT) with 2°1T1 constituted the only scinfi- 
graphic technique available for detecting CAD and deter- 
mining prognosis. The major limitation of 2°1T1 
scintigraphy is a high false-positive rate for CAD detection 
experienced in many laboratories, which is predominantly 
attributed to image attenuation artifacts (8). In the past 
decade, new 99mTc-labeled perfusion imaging agents were 
introduced to clinical practice that provided image quality 
superior to that achieved with 2°1T1 because of the more 
favorable physical characteristics of 99mTc for imaging with 
a SPECT camera. Sensitivity for CAD detection was 
comparable for 99mTc-sestamibi and 2°1T1 images, but 
99mTc-sestamibi yielded enhanced specificity. The Berman 
article demonstrated the incremental value for determining 
prognosis over clinical and exercise treadmill test (ETT) 
data utilizing a dual-imaging protocol (rest 2°lT1/exercise 
99mTc-sestamibi) in 1,702 patients who were followed after 
testing for 20 + 5 months. In this study, patients were 
divided into low, intermediate and high pretest likelihood of 
CAD on the basis of clinical and exercise ECG stress test 
data. 99mTc-sestamibi scan results further separated patients 
into lower and higher risk subgroups. One very important 
finding in this landmark study was that the cardiac event 
rate for patients with normal scans was low for all levels of 
prescan likelihood of CAD. For example, of the 90 patients 
who were classified as having a >85% likelihood of CAD 
after the ETT, and who had a normal scan, none had a 
cardiac event during follow-up. Thus, the cardiac event rate 
in patients with a normal 99mTc-sestamibi SPECT study 
was very low, even when clinical and exercise stress test 
variables uggested a high risk of CAD. The rates of referral 
to catheterization after 99mTc-sestamibi SPECT imaging 
were also low in patients with normal perfusion studies, 
even if they had a high likelihood of CAD when analyzing 
only the clinical and ETT results. 
The Berman study was one of the first to provide data 
concerning the cost benefit of nuclear testing. The nuclear 
scan was cost-effective in patients with interpretable exercise 
ECG responses and an intermediate-to-high post-ETT 
likelihood of CAD and in those with uninterpretable 
exercise ECG responses and an intermediate-to-high pre- 
ETT likelihood of CAD. In contrast, nuclear testing was 
not cost-effective in patients who had a low likelihood of 
having CAD after ETT. Going directly to catheterization 
based on the ETT alone cost $2,089 per patient as com- 
pared with $1,729 per patient when only patients with 
abnormal nuclear scan results were referred to catheteriza- 
tion. 
Subsequent prognostic studies. After the publication of 
the Berman study, the Cedars-Sinai group continued to 
evaluate the prognostic value of exercise SPECT. In a study 
by Hachamovitch et al. (9), nuclear testing was found to add 
significant incremental prognostic value to the Duke tread- 
mill score for risk assessment. There were 834 patients 
classified as having an intermediate risk of subsequent death 
infarction on the basis of the Duke treadmill score who had 
a normal scan. The subsequent hard event rate was 0.4% 
during follow-up of this group. Multiple logistic regression 
analysis revealed that scan information from 99mTc- 
sestamibi SPECT contributed 95% of all the information 
regarding referral to catheterization. I  another publication 
by Hachamovitch et al. (10), the Cedars-Sinai group re- 
ported that during exercise 99mTc-sestamibi SPECT pro- 
vided incremental prognostic value for both men and 
women. In fact, receiver operating characteristic (ROC) 
analysis demonstrated superior discrimination for the nu- 
clear scan results in identifying high-risk women than men 
(area under curve: 0.84 in women vs. 0.71 in men; p < 
0.0005). In that study, the odds ratio comparing events of 
patients with abnormal scan results versus those with 
normal scan results was greater in women than in men, 
suggesting superior stratification using SPECT imaging in 
women. When added to the clinical and exercise model in a 
Cox proportional hazards analysis, nudear data provided 
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17% more prognostic information in men and 37% more in 
women when compared with clinical and exercise variables 
:done. That  study comprised 2,742 men and 1,394 women 
who underwent the dual-isotope SPECT protocol and were 
followed for an average of 20 ± 5 months. 
The Cedars-Sinai group went on to demonstrate in a 
retrospective analysis of their patient cohort that the results 
of SPECT imaging might assist in deciding which patients 
with abnormal scans would do well with medical therapy 
compared with early revascularization (11). They found that 
the annual cardiac death rate was only 0.8% in patients with 
mildly abnormal stress perfusion scans who received medical 
treatment after testing compared with an annual death rate 
of 0.9% in patients with a mildly abnormal scan who 
underwent early revascularization after testing. In contrast, 
patients with moderately abnormal and severely abnormal 
scans (more extensive defects) benefited from revasculariza- 
uon early after nuclear testing. 
Finally, the Cedars-Sinai group, in conjunction with 
several other institutions, prospectively enrolled 11,372 
consecutive stable chest pain patients who had been referred 
for stress myocardial perfusion imaging or cardiac catheter- 
ization (12). The stress imaging patients and the direct 
catheterization patients were matched by their pretest clin- 
ical risk of CAD (low, intermediate and high). The com- 
posite three-year cost of care for the two management 
~trategies was compiled. These strategies were an initial 
,tress perfusion SPECT with selective catheterization of 
high-risk patients (clinically high risk and those with 
i,~chemia on SPECT) or direct catheterization as the initial 
diagnostic approach to diagnosing CAD. The investigators 
(ound that diagnostic and follow-up costs of care were 30% 
to 41% higher for the patients undergoing direct catheter- 
ization in all pretest clinical risk subsets. The costs for the 
direct cardiac catheterization strategy ranged from $2,878 to 
54,579 compared with $2,387 to $3,010 (p < 0.001) for the 
stress perfusion imaging plus selective catheterization strat- 
egy. 
Influence on the field. These clinical observational studies 
reported by Berman et al. (1)--describing the supplemen- 
t~try diagnostic and prognostic value, as well as the cost- 
effectiveness, of  stress myocardial perfusion imaging over 
clinical and exercise ECG stress test data in large numbers 
~f men and women with suspected or known CAD- -have  
had a great influence on the area of clinical decision making. 
Risk stratification and management s rategies were devel- 
oped based on studies in which known outcome was linked 
to noninvasive imaging variables, such as the extent of 
stress-induced hypoperfusion. The concept has thus 
emerged that stress myocardial perfusion imaging may 
function as a "gatekeeper" for referral for invasive strategies 
because it may identify low-risk groups who have an 
excellent prognosis treated with medical therapy and do not 
benefit from early revascularization. Conversely, the identi- 
fication of high-risk patients who would most likely benefit 
from early revascularization  the basis of an expected high 
cardiac event rate with medical treatment can also be 
accomplished. This management approach, in which refer- 
ral for cardiac catheterization is ischemia driven, is also 
highly cost-effective. 
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